NA
SOPH icon

Nordwand Advisors’s SOPHiA GENETICS SOPH Stock Holding History

Nordwand Advisors’s Portfolio SOPH Stock Details SOPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-500
Closed -$2.46K – 174
2024
Q1 		$2.46K Sell
500
-1,500
-75% -$7.24K ﹤0.01% 150
2023
Q4 		$9.42K Hold
2,000
– – ﹤0.01% 113
2023
Q3 		$5.09K Hold
2,000
– – ﹤0.01% 107
2023
Q2 		$8.96K Hold
2,000
– – ﹤0.01% 95
2023
Q1 		$9.94K Buy
+2,000
New +$6.47K ﹤0.01% 102

Other funds holding SOPH

GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
ACM
AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return
AWA
Alta Wealth Advisors Woburn, Massachusetts $308M AUM 27.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return

Nordwand Advisors's SOPH Position: Q2 2024 in Review

Nordwand Advisors sold out of SOPHiA GENETICS (SOPH) in Q2 2024, closing a stake of 500 shares — an estimated $2.46K sold.

Nordwand Advisors first reported a position in SOPH in Q1 2023 and held it in 5 quarters. The position peaked at $9.94K in Q1 2023. 31 funds tracked by Wall St. Rank hold SOPH as of Q2 2024.

  • Nordwand Advisors reported no remaining SOPHiA GENETICS position as of Q2 2024 after selling out during the quarter.
  • Nordwand Advisors sold 500 SOPHiA GENETICS shares in Q2 2024, an estimated $2.46K.
  • Nordwand Advisors first reported a position in SOPHiA GENETICS in Q1 2023 and held it in 5 quarters.
  • Nordwand Advisors's SOPHiA GENETICS position peaked at $9.94K in Q1 2023.
  • 31 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q2 2024.

Based on Nordwand Advisors's 13F filing for Q2 2024, filed 5 Aug 2024.